GT200600286A - Diagnostico de artritis reumatoide por imagenes opticas - Google Patents

Diagnostico de artritis reumatoide por imagenes opticas

Info

Publication number
GT200600286A
GT200600286A GT200600286A GT200600286A GT200600286A GT 200600286 A GT200600286 A GT 200600286A GT 200600286 A GT200600286 A GT 200600286A GT 200600286 A GT200600286 A GT 200600286A GT 200600286 A GT200600286 A GT 200600286A
Authority
GT
Guatemala
Prior art keywords
diagnosis
rheumatoid arthritis
optical images
dyes
disease
Prior art date
Application number
GT200600286A
Other languages
English (en)
Inventor
Kai Licha
Michael Schirner
Axel Vater
Sonja Vollmer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600286A publication Critical patent/GT200600286A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6825—Hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4528—Joints
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE AL USO DE TINTURAS DE INDOCARBOCIANINA, EN PARTICULAR TINTURAS DE VINDOTRICARBOCIANINA PARA EL DIAGNÓSTICO DE ENFERMEDADES INFLAMATORIAS, EN PARTICULAR ARTRITIS REUMATOIDE, MÉTODOS PARA DIAGNOSTICAR ENFERMEDADES INFLAMATORIAS Y UN APARATO ÚTIL PARA LLEVAR A CABO EL MÉTODO DE DIAGNÓSTICO. T2006
GT200600286A 2005-06-29 2006-06-29 Diagnostico de artritis reumatoide por imagenes opticas GT200600286A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69466905P 2005-06-29 2005-06-29
EP05015365A EP1743658A1 (en) 2005-07-14 2005-07-14 Optical imaging of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
GT200600286A true GT200600286A (es) 2007-03-14

Family

ID=35276318

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600286A GT200600286A (es) 2005-06-29 2006-06-29 Diagnostico de artritis reumatoide por imagenes opticas

Country Status (15)

Country Link
US (2) US7879314B2 (es)
EP (3) EP1743658A1 (es)
AR (1) AR057420A1 (es)
AT (1) ATE537848T1 (es)
CA (1) CA2619034C (es)
DK (1) DK1931391T3 (es)
DO (1) DOP2006000155A (es)
ES (1) ES2379585T3 (es)
GT (1) GT200600286A (es)
PE (1) PE20070465A1 (es)
PL (1) PL1931391T3 (es)
SI (1) SI1931391T1 (es)
TW (1) TW200744643A (es)
UY (1) UY29642A1 (es)
WO (1) WO2007000349A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4445065A1 (de) * 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
EP1743658A1 (en) * 2005-07-14 2007-01-17 Schering Aktiengesellschaft Optical imaging of rheumatoid arthritis
NZ583011A (en) * 2007-08-14 2012-12-21 Mivenion Gmbh Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis
US20090253990A1 (en) * 2007-12-06 2009-10-08 Children's Hospital Of Orange County Optical diagnosis of hemophilic joint effusion
WO2009147560A2 (en) * 2008-05-26 2009-12-10 Koninklijke Philips Electronics N.V. Optical detection method and device for optical detection of the condition of joints
WO2010049855A1 (en) * 2008-10-27 2010-05-06 Koninklijke Philips Electronics N.V. Device and method for optically examining the interior of a body part
WO2010064200A1 (en) * 2008-12-05 2010-06-10 Koninklijke Philips Electronics N.V. Method and device for optically examining the condition of joints
EP2378953B1 (en) * 2008-12-05 2017-08-16 Hemics B.V. Device for optical detection of the condition of joints
EP2199208B1 (de) 2008-12-17 2012-08-01 Mettler-Toledo AG Dosiervorrichtung
GB201015806D0 (en) 2010-09-21 2010-10-27 Ge Healthcare As Vascular imaging agents
US9585972B2 (en) 2011-05-09 2017-03-07 Sherry L. Thornton Method for imaging a site of arthritis in an animal
CN103070670B (zh) * 2013-01-28 2014-11-12 厦门大学 一种早期骨性关节炎检测系统
EP3015069A1 (en) 2014-10-30 2016-05-04 Universitätsklinikum Jena Apparatus for suspended ultrasonography and corresponding method
JP6480769B2 (ja) * 2015-03-18 2019-03-13 キヤノン株式会社 撮影装置、撮影システム及び撮影装置で用いられる支持部材
US9862682B2 (en) 2016-01-08 2018-01-09 BroadPharm Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL241413A (es) 1957-06-05
ES2217408T3 (es) 1996-04-01 2004-11-01 Epix Medical, Inc. Agentes diagnosticos de contraste para formacion de imagenes bioactivados.
EP0971624A1 (en) * 1997-03-13 2000-01-19 Biomax Technologies, Inc. Methods and apparatus for detecting the rejection of transplanted tissue
DE19717904A1 (de) * 1997-04-23 1998-10-29 Diagnostikforschung Inst Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie
EP0979107A1 (en) 1997-04-29 2000-02-16 Nycomed Imaging As Light imaging contrast agents
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
US6530944B2 (en) 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6498941B1 (en) * 2000-03-09 2002-12-24 Advanced Cardiovascular Systems, Inc. Catheter based probe and method of using same for detecting chemical analytes
US6615063B1 (en) * 2000-11-27 2003-09-02 The General Hospital Corporation Fluorescence-mediated molecular tomography
DE10059070C1 (de) * 2000-11-28 2002-02-14 Pulsion Medical Sys Ag Vorrichtung zur Bestimmung von Gewebeperfusion und intraoperative Verwendung
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
AU2002305148A1 (en) * 2001-04-05 2002-10-21 Johns Hopkins University Imaging systems for in vivo protocols
US20020197261A1 (en) 2001-04-26 2002-12-26 Chun Li Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
AU2003228418A1 (en) * 2002-03-29 2003-10-13 The General Hospital Corporation Nir-fluorescent cyanine dyes, their synthesis and biological use
WO2004028449A2 (en) 2002-09-24 2004-04-08 The General Hospital Corporation Azulene dimer-quenched, near-infrared fluorescent probes
WO2005019247A2 (en) 2003-08-15 2005-03-03 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
US20080308744A1 (en) * 2003-11-18 2008-12-18 Beth Israel Deaconess Medical Center Serum Albumin Conjugated to Fluorescent Substances for Imaging
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
EP1743658A1 (en) * 2005-07-14 2007-01-17 Schering Aktiengesellschaft Optical imaging of rheumatoid arthritis

Also Published As

Publication number Publication date
PL1931391T3 (pl) 2012-05-31
ES2379585T3 (es) 2012-04-27
US7879314B2 (en) 2011-02-01
SI1931391T1 (sl) 2012-04-30
UY29642A1 (es) 2007-01-31
EP1931391A2 (en) 2008-06-18
WO2007000349A3 (en) 2007-03-15
DOP2006000155A (es) 2007-11-30
AR057420A1 (es) 2007-12-05
EP1743658A1 (en) 2007-01-17
PE20070465A1 (es) 2007-06-07
EP1931391B1 (en) 2011-12-21
WO2007000349A2 (en) 2007-01-04
CA2619034A1 (en) 2007-01-04
US20070059244A1 (en) 2007-03-15
ATE537848T1 (de) 2012-01-15
EP1745739A3 (en) 2009-04-22
CA2619034C (en) 2014-11-25
US20110098578A1 (en) 2011-04-28
EP1745739A2 (en) 2007-01-24
DK1931391T3 (da) 2012-03-12
TW200744643A (en) 2007-12-16

Similar Documents

Publication Publication Date Title
GT200600286A (es) Diagnostico de artritis reumatoide por imagenes opticas
ES2532502T3 (es) Proceso para la preparación de tenofovir
ES2500066T3 (es) Anticuerpos frente a ferroportina y métodos de uso
EA201100231A1 (ru) Диагностический анализ на основе антител
CR20110646A (es) Anticuerpo anti-axl
ES2481641T3 (es) Uso de receptor inmunosupresor
CO6710903A2 (es) Un anticuerpo que reconoce y se une específicamente con un fosfo-epítope en la proteína tau de mamífero o en uno de sus fragmentos y una composición comprendiendo el mismo
GT201200058A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
BR112012005338A2 (pt) anticorpos humanos de afinidade alta para receptor-2 ativado por protease humana.
ECSP10010580A (es) Inmunoglobulinas duales de dominio variable y sus aplicaciones
AR054479A1 (es) Metodo para diagnosticar l a enfermedad de alzheimer
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
AR049411A1 (es) Metodo de diagnostico de lawsonia intracellularis
AR088244A1 (es) oxMIF COMO MARCADOR DE DIAGNOSTICO
ES1061127Y (es) Jaula para el cultivo acuatico de moluscos.
WO2009000777A3 (en) Imaging diagnostics by combining contrast agents
UY32112A (es) Compuestos que se unen a las placas amiloides para obtener imágenes de las mismas y su uso
FR2898412B1 (fr) Procede de reconstruction d'une image de tomographie optique par fluorescence d'un objet a contour quelconque
EA201301029A1 (ru) Диагностический анализ на основе антител
MA33514B1 (fr) Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)
RU2007129294A (ru) Противосудорожное средство
PA8776801A1 (es) Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de trastornos motores asociados a la enfermedad de parkinson.
BRPI0816181A2 (pt) Anticorpos modificadores de doença cancerígena.
ZA200906225B (en) Cancer disease modifying antibody 010207-01 produced by hybridoma cell line AR51A630.3
TH45348S1 (th) อุปกรณ์ยึดสำหรับอุปกรณ์ดันดิน